Takeda Pharmaceutical Co Ltd (TKPHF)
Takeda Pharmaceutical Market Cap: 41.80B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 41.80B |
May 16, 2024 | 41.80B |
May 15, 2024 | 41.80B |
May 14, 2024 | 40.83B |
May 13, 2024 | 42.10B |
May 10, 2024 | 42.10B |
May 09, 2024 | 42.10B |
May 08, 2024 | 40.07B |
May 07, 2024 | 41.76B |
May 06, 2024 | 41.76B |
May 03, 2024 | 41.76B |
May 02, 2024 | 41.76B |
May 01, 2024 | 41.76B |
April 30, 2024 | 40.88B |
April 29, 2024 | 40.88B |
April 26, 2024 | 40.88B |
April 25, 2024 | 39.29B |
April 24, 2024 | 40.43B |
April 23, 2024 | 40.43B |
April 22, 2024 | 40.43B |
April 19, 2024 | 40.43B |
April 18, 2024 | 41.61B |
April 17, 2024 | 41.61B |
April 16, 2024 | 41.61B |
April 15, 2024 | 41.61B |
Date | Value |
---|---|
April 12, 2024 | 41.61B |
April 11, 2024 | 41.61B |
April 10, 2024 | 41.61B |
April 09, 2024 | 42.44B |
April 08, 2024 | 41.72B |
April 05, 2024 | 42.76B |
April 04, 2024 | 41.46B |
April 03, 2024 | 41.89B |
April 02, 2024 | 41.89B |
April 01, 2024 | 43.79B |
March 28, 2024 | 44.64B |
March 27, 2024 | 44.64B |
March 26, 2024 | 44.64B |
March 25, 2024 | 44.64B |
March 22, 2024 | 45.39B |
March 21, 2024 | 45.39B |
March 20, 2024 | 45.39B |
March 19, 2024 | 45.39B |
March 18, 2024 | 45.39B |
March 15, 2024 | 45.39B |
March 14, 2024 | 45.39B |
March 13, 2024 | 46.16B |
March 12, 2024 | 46.16B |
March 11, 2024 | 46.55B |
March 08, 2024 | 46.55B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Nxera Pharma Co Ltd | 869.77M |
PeptiDream Inc | 1.555B |
Healios KK | 86.98M |
AnGes Inc | 72.99M |
Market Cap Related Metrics
PE Ratio | 41.41 |
PS Ratio | 1.426 |
Price to Book Value | 0.8698 |
Price to Free Cash Flow | 25.80 |
Price | 26.64 |
Earnings Yield | 2.41% |
Operating PE Ratio | 33.20 |
Normalized PE Ratio | 41.41 |